| Aurobindo Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524804 |
NSE Symbol : AUROPHARMA |
P/E(TTM) : 38.02 |
|
ISIN Demat : INE406A01037 |
Div & Yield% : 0.25 |
EPS(TTM) : 41.81 |
|
Book Value(₹) : 391.14 |
Market Cap(₹Cr) : 92,318.42 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,781.69 | 2,746.98 | 2,726.38 | 2,759.89 | 2,822.14 | 2,721.43 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,781.69 | 2,746.98 | 2,726.38 | 2,759.89 | 2,822.14 | 2,721.43 |
| Other Operating Income | 17.82 | 39.57 | 20.90 | 29.83 | 26.03 | 10.56 |
| Other Income | 241.89 | 214.09 | 130.15 | 159.52 | 83.77 | 113.98 |
| Total Income | 3,041.40 | 3,000.64 | 2,877.43 | 2,949.24 | 2,931.94 | 2,845.97 |
| Total Expenditure | 1,917.26 | 2,005.13 | 1,975.18 | 2,065.02 | 2,051.83 | 2,135.48 |
| PBIDT | 1,124.14 | 995.51 | 902.25 | 884.22 | 880.11 | 710.49 |
| Interest | 47.07 | 47.27 | 48.43 | 57.45 | 60.00 | 61.09 |
| PBDT | 1,077.07 | 948.24 | 853.82 | 826.77 | 820.11 | 649.40 |
| Depreciation | 68.99 | 71.93 | 71.92 | 71.49 | 70.02 | 93.88 |
| Tax | 271.50 | 181.95 | 202.97 | 174.22 | 187.68 | 155.25 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.64 | 2.13 | -3.14 | -0.31 | 3.28 | -7.90 |
| Reported Profit After Tax | 737.22 | 692.23 | 582.07 | 581.37 | 559.13 | 408.17 |
| Extra-ordinary Items | 0.00 | 0.00 | -12.87 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 737.22 | 692.23 | 594.94 | 581.37 | 559.13 | 408.17 |
| EPS (Unit Curr.) | 12.75 | 11.92 | 10.02 | 10.10 | 9.63 | 7.03 |
| EPS (Adj) (Unit Curr.) | 12.75 | 11.92 | 10.02 | 10.10 | 9.63 | 7.03 |
| Calculated EPS (Unit Curr.) | 12.81 | 11.92 | 10.02 | 10.01 | 9.63 | 7.03 |
| Calculated EPS (Adj) (Unit Curr.) | 12.81 | 11.92 | 10.02 | 10.01 | 9.63 | 7.03 |
| Calculated EPS (Ann.) (Unit Curr.) | 51.25 | 47.67 | 40.09 | 40.04 | 38.51 | 28.11 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 51.25 | 47.67 | 40.09 | 40.04 | 38.51 | 28.11 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 400.00 | 0.00 |
| Equity | 57.54 | 58.08 | 58.08 | 58.08 | 58.08 | 58.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 40.41 | 36.24 | 33.09 | 32.04 | 31.19 | 26.11 |
| PBDTM(%) | 38.72 | 34.52 | 31.32 | 29.96 | 29.06 | 23.86 |
| PATM(%) | 26.50 | 25.20 | 21.35 | 21.06 | 19.81 | 15.00 |
